1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
申请人:Abbisko Therapeutics Co., Ltd.
公开号:US20220009894A1
公开(公告)日:2022-01-13
A 1,2,3,4-tetrahydroquinoxaline derivative having a structure as represented by formula (I), preparation method therefor and application thereof. These compounds can be widely applied to preparation of drugs for treating one or more tumors, cancers, metabolic diseases, autoimmune diseases or disorders, and a new generation of RORγt agonist drugs is expected to be developed.
一种具有如公式(I)所示结构的1,2,3,4-四氢喹喔啉衍生物,其制备方法及应用。这些化合物可以广泛应用于制备用于治疗一个或多个肿瘤、癌症、代谢性疾病、自身免疫疾病或紊乱的药物,预计将开发出新一代RORγt激动剂药物。